| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/14/2004 | EP1379515A1 Lipid lowering biphenylcarboxamides |
| 01/14/2004 | EP1379514A2 5-membered heterocycles, preparation and application thereof as medicaments |
| 01/14/2004 | EP1379511A1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
| 01/14/2004 | EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 01/14/2004 | EP1379508A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 01/14/2004 | EP1379507A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 01/14/2004 | EP1379506A2 Substituted carboxamides |
| 01/14/2004 | EP1379505A2 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 01/14/2004 | EP1379504A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors |
| 01/14/2004 | EP1379501A1 Indolinones, substituted in position 6, and their use as kinase inhibitors |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | EP1379252A2 Nociceptin analogs |
| 01/14/2004 | EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 01/14/2004 | EP1379246A1 Nociceptin analogs |
| 01/14/2004 | EP1379241A1 Compounds and methods |
| 01/14/2004 | EP1379240A1 Compounds and methods |
| 01/14/2004 | EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/14/2004 | EP1379237A2 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379234A1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
| 01/14/2004 | EP1379138A1 Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 01/14/2004 | EP1272189A4 Inhibition of cyclooxygenase-2 activity |
| 01/14/2004 | EP1197487B1 Benzimidazole compounds and drugs containing the same |
| 01/14/2004 | EP1112265B1 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 01/14/2004 | CN1468233A Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468230A Chemical compounds |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468225A 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 01/14/2004 | CN1468224A Derivatives of quinoline as alpha-2 antagonists |
| 01/14/2004 | CN1468222A N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3 receptor antagonists |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468220A New piperidine derivatives |
| 01/14/2004 | CN1468217A Aliphatic nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1468216A Nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468112A The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/14/2004 | CN1467207A Method for preparing solid optical pure neutral S- (-) - and (R) - (+) -Omeprazole |
| 01/14/2004 | CN1134442C Pyrazolopyrimidinone cGMPPDE 5 inhibitors, method for preparing the same and uses and intermediate |
| 01/14/2004 | CN1134433C Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 01/14/2004 | CN1134432C Omeprazole sodium salt |
| 01/14/2004 | CN1134431C 2,4-diaminopyrimidine derivatives as dopamine D4 receptor antagonists |
| 01/14/2004 | CN1134430C Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/14/2004 | CN1134423C Adhesion receptor antagonists |
| 01/14/2004 | CN1134420C Novel substituted imidazole compounds |
| 01/14/2004 | CN1134418C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/14/2004 | CN1134417C 3-phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 01/14/2004 | CN1134412C N-substituted 2-cyanopyrodlidines |
| 01/14/2004 | CN1134264C Antithrombotic agents |
| 01/14/2004 | CN1134259C Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperdines)-butylazols in preparation of a medicament for the treatment of pain |
| 01/13/2004 | US6677455 Potassium salt of S-omeprazole |
| 01/13/2004 | US6677454 Piperidine monoamine transporter ligands, comprising functional group capable of chelating radionuclides |
| 01/13/2004 | US6677452 Pyridine carboxamide or sulfonamide derivatives and combinatorial libraries thereof |
| 01/13/2004 | US6677451 Polymer stabilizers; oxygen, heat, radiation resistances; discoloration inhibition; coatings; fibers; tapes; films; papermaking; hals; fireproofing; oxidation of a 1-allyl-substituted sterically hindered amine |
| 01/13/2004 | US6677369 Antithrombotic agents |
| 01/13/2004 | US6677368 4-aryl substituted indolinones |
| 01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677340 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/13/2004 | US6677339 S-3-(4-(3,5-dichloropyrid-4-ylcarboxamido)phenyl)-2-(4,6-dimet hoxy-1,3,5-triazin-2-ylamino)propanoic acid for example; inhibit binding of alpha 4 integrins to their ligands, for treating immune or inflammatory disorders |
| 01/13/2004 | US6677337 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines |
| 01/13/2004 | US6677335 Pharmaceutically active compounds |
| 01/13/2004 | US6677333 2H-phthalazin-1-one derivatives and drug containing its derivatives as active ingredient |
| 01/13/2004 | US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus |
| 01/13/2004 | US6677330 Acetylcholinesterase inhibitors; treating alzheimer*s disease, attention deficit, hyperactivity and brain disorders |
| 01/13/2004 | US6677110 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/13/2004 | CA2280850C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
| 01/08/2004 | WO2004002984A2 Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules |
| 01/08/2004 | WO2004002983A2 Therapeutic piperazine derivatives useful for treating pain |
| 01/08/2004 | WO2004002982A2 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
| 01/08/2004 | WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 01/08/2004 | WO2004002964A1 Diaminopyrimidinecarboxa mide derivative |
| 01/08/2004 | WO2004002963A1 Amide derivative |
| 01/08/2004 | WO2004002960A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | WO2004002956A2 Asymmetric synthesis of amino-pyrrolidinones and a crystalline, free-base amino-pyrrolidinone |
| 01/08/2004 | WO2004002948A1 Amide compound and medicinal use thereof |
| 01/08/2004 | WO2004002489A1 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis |
| 01/08/2004 | WO2004002485A1 Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor |
| 01/08/2004 | WO2004002483A1 Substituted 3- and 4- aminomethylpiperidines for use as beta-secretase in the treatment of alzheimer’s disease |
| 01/08/2004 | WO2004002409A2 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | WO2003090912A9 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/08/2004 | WO2003087088A3 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
| 01/08/2004 | WO2003086279A3 Inhibitors of akt activity |
| 01/08/2004 | WO2003076429A3 Azepane derivatives and their use as atk1 inhibitors |
| 01/08/2004 | WO2003062206A3 Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006233 Synthetic multimerizing agents |
| 01/08/2004 | US20040006230 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 01/08/2004 | US20040006229 Indole derivatives for the treatment of depression and anxiety |
| 01/08/2004 | US20040006137 Asymmetric synthesis of amino-pyrrolidinones and a crystalline, free-base amino-pyrrolidinone |
| 01/08/2004 | US20040006123 Interleukin-4 gene expression inhibitors |
| 01/08/2004 | US20040006111 Transmucosal delivery of proton pump inhibitors |
| 01/08/2004 | US20040006110 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 01/08/2004 | US20040006109 Proton pump inhibitors and liquid vehicle having a pH greater than 6.5 and a viscosity sufficient to maintain a uniform suspension |
| 01/08/2004 | US20040006107 For prophylaxis of asthma and other allergic diseases |
| 01/08/2004 | US20040006106 For therapy of breast cancer in mammals |
| 01/08/2004 | US20040006101 Quinolinone derivatives |
| 01/08/2004 | US20040006099 Amidine compounds |
| 01/08/2004 | US20040006098 Induce cytokine biosynthesis in animals |